Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Back

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

Completed

Open to: ALL

Age: 18.0 - N/A

Nottingham Cambridge Sheffield Sutton In Ashfield

Medical Conditions

Crohn Disease

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The purpose of the study is to assess the safety and efficacy of JNJ-64304500 in participants with moderately to severely active Crohn's disease.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Aug 2016 Dec 2020

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : Participants will receive JNJ-64304500 Subcutaneously.

Intervention Arm Group : Part I : JNJ-64304500;Part I : Placebo;Part II : JNJ-64304500 High Dose;Part II : JNJ-64304500 Low Dose;Part II : JNJ-64304500 Middle Dose;Part II : Placebo;

Intervention Type : DRUG
Intervention Description : Participants will receive placebo Subcutaneously.

Intervention Arm Group : Part I : Placebo;Part II : Placebo;

Intervention Type : DRUG
Intervention Description : Participants will receive ustekinumab as per the dosing regimen.

Intervention Arm Group : Part II : Ustekinumab;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Nottingham
  • Cambridge
  • Sheffield
  • Sutton In Ashfield


The study is sponsored by Janssen Research & Development, LLC



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT02877134
Last updated 29 March 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top